Evidence map›Paper›PMID 19723623›Full record

ArticleThe Journal of biological chemistry2009

Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase.

Zsolt Ablonczy, Annamalai Prakasam, James Fant, Abdul Fauq, Craig Crosson, Kumar Sambamurti

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Notch Signaling in Acute Inflammation and Sepsis.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zsolt AblonczyDepartment of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Annamalai Prakasam
James Fant
Abdul Fauq
Craig Crosson
Kumar Sambamurti
Medical University of South Carolina · USJacksonville College · US

Funding

ADENOSINE AGONISTS--POTENTIAL ANTIGLAUCOMA DRUGSR01EY009741 · NEI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI CROSSON, CRAIG E. · 1993 to 2010
$3.9M
ROD NEURODEGENERATIVE AND PROTECTIVE GENESR01EY013520 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ROHRER, BAERBEL · 2001 to 2005
$1.6M
Regulation and Cell Biology of Beta-SecretaseR01AG023055 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SAMBAMURTI, KUMAR · 2004 to 2008
$1.2M
Core Resources for Vision Research at MUSCR24EY014793 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROSSON, CRAIG E. · 2003 to 2007
$1.0M
NEI NIH HHS EY009741NEI NIH HHS EY13520NEI NIH HHS EY14793NEI NIH HHS R01 EY009741NEI NIH HHS R01 EY013520NEI NIH HHS R24 EY014793NIA NIH HHS AG023055NIA NIH HHS R01 AG023055
6 · The paper itself

Abstract

Wet age-related macular degeneration (AMD) attacks the integrity of the retinal pigment epithelium (RPE) barrier system. The pathogenic process was hypothesized to be mediated by vascular endothelial growth factor (VEGF) and antagonized by pigment epithelium-derived factor (PEDF). To dissect these functional interactions, monolayer cultures of RPE cells were established, and changes in transepithelial resistance were evaluated after administration of PEDF, placenta growth factor (VEGF-R1 agonist), and VEGF-E (VEGF-R2 agonist). A recently described mechanism of VEGF inhibition in endothelia required the release of VEGF-R1 intracellular domain by gamma-secretase. To evaluate this pathway in the RPE, cells were pretreated with inhibitors DAPT or LY411575. Processing of VEGF receptors was assessed by Western blot analysis. Administration of VEGF-E rapidly increased RPE permeability, and PEDF inhibited the VEGF-E response dose-dependently. Both gamma-secretase antagonists prevented the inhibitory effects of PEDF. The co-administration of PEDF and VEGF-E depleted the amount of VEGF-R2 in the membrane and increased the amount of VEGF-R2 ectodomain in the media. Therefore, the inhibitory effect of PEDF appears to be mediated via the processing of VEGF-R2 by gamma-secretase. gamma-Secretase generates the amyloid-beta (Abeta) peptide of Alzheimer disease from its precursor (amyloid precursor protein). This peptide is also a component of drusen in dry AMD. The results support the hypothesis that misregulation of gamma-secretase may not only lead to Abeta deposits in dry AMD but can also be damaging to RPE function by blocking the protective effects of PEDF to prevent VEGF from driving the dry to wet AMD transition.

Indexed as

Signal TransductionAmyloid Precursor Protein SecretasesAnimalsCells, CulturedEye ProteinsHumansMacular DegenerationNerve Growth FactorsPermeabilityPigment Epithelium-Derived FactorRetinal Pigment EpitheliumSerpinsSwineVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Amyloid Precursor Protein SecretasesEye ProteinsNerve Growth FactorsPigment Epithelium-Derived FactorSerpinsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID19723623
PMCPMC2781573
OpenAlexW2118741073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.